What we do
Liminal BioSciences is a global biotechnology company that specialises in discovering, developing and commercializing novel small molecule compounds for respiratory, liver and renal diseases. We focus specifically on developing solutions for rare and orphan diseases. Liminal is headquartered in Laval, Quebec (Canada), has R&D facilities in Canada, the United Kingdom (“UK”) and the United States (“USA”), manufacturing facilities in Canada and the Isle of Man and corporate and business development activities in Canada, the USA, Europe and Asia.
Everything we achieve is because of our people. We are committed to becoming a truly great place to work and ensure that we have an open, diverse and inclusive working culture based on trust and mutual respect. We believe that what we do today will change lives tomorrow and we are committed to rewarding people for turning that aspiration into a reality.
Liminal drives a culture of innovation
We are constantly discovering new innovations for the development of best in class products and orphan drugs that target unmet medical conditions and rare diseases in respiratory, liver and renal diseases. We do it not because we have to but because we are compelled to. It’s at the heart of our culture to provide a pathway to hope.
Diversity & community
Liminal is an equal opportunity employer and has opportunities globally for hardworking passionate people in research, development, manufacturing and marketing. We believe breakthrough therapeutics can best be discovered and brought to fruition when teams are inclusive and diverse.